{"organizations": [], "uuid": "f755df38c5cc412caa23cec315c8284dc3f7a568", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-labcorp-reports-q1-earnings-per-sh/brief-labcorp-reports-q1-earnings-per-share-1-67-idUSASC09X9D", "country": "US", "domain_rank": 408, "title": "BRIEF-LabCorp Reports Q1 Earnings Per Share $1.67", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-04-25T14:11:00.000+03:00", "replies_count": 0, "uuid": "f755df38c5cc412caa23cec315c8284dc3f7a568"}, "author": "", "url": "https://www.reuters.com/article/brief-labcorp-reports-q1-earnings-per-sh/brief-labcorp-reports-q1-earnings-per-share-1-67-idUSASC09X9D", "ord_in_thread": 0, "title": "BRIEF-LabCorp Reports Q1 Earnings Per Share $1.67", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "reuters", "sentiment": "negative"}, {"name": "labcorp", "sentiment": "none"}, {"name": "reuters) - laboratory corporation of america holdings", "sentiment": "none"}, {"name": "thomson reuters", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "April 25 (Reuters) - Laboratory Corporation of America Holdings:\n* LABCORP ANNOUNCES STRONG 2018 FIRST QUARTER RESULTS AND UPDATES 2018 GUIDANCE\n* Q1 EARNINGS PER SHARE $1.67 * Q1 REVENUE $2.85 BILLION VERSUS I/B/E/S VIEW $2.77 BILLION\n* SEES FY 2018 ADJUSTED EARNINGS PER SHARE $11.30 TO $11.70\n* Q1 ADJUSTED EARNINGS PER SHARE $2.78 * Q1 EARNINGS PER SHARE VIEW $2.63 — THOMSON REUTERS I/B/E/S\n* BOARD AUTHORIZED AN INCREASE IN COMPANY’S TOTAL SHARE REPURCHASE PROGRAM TO A TOTAL OF $1.0 BILLION\n* 2018 FREE CASH FLOW GUIDANCE OF $1.1 BILLION TO $1.2 BILLION, UNCHANGED FROM PRIOR GUIDANCE\n* 2018 ADJUSTED EPS GUIDANCE OF $11.30 TO $11.70, UNCHANGED FROM PRIOR GUIDANCE\n* 2018 ADJUSTED EPS GUIDANCE NOW INCLUDES PROJECTED NEGATIVE IMPACT FROM ASC 606 OF ABOUT $0.20 TO $0.30 PER SHARE FOR FULL YEAR 2018\n* EFFECTIVE JANUARY 1, 2018, COMPANY ADOPTED FASB-ISSUED CONVERGED STANDARD ON REVENUE RECOGNITION (ASC 606)\n* SEES 2018 REVENUE GROWTH OF 10.0% TO 12.0% OVER 2017 REVENUE OF $10.31 BILLION\n* BACKLOG AT END OF QUARTER WAS $9.17 BILLION FOR COVANCE DRUG DEVELOPMENT Source text for Eikon: Further company coverage:\n ", "external_links": [], "published": "2018-04-25T14:11:00.000+03:00", "crawled": "2018-04-25T14:24:30.004+03:00", "highlightTitle": ""}